Diabetic Retinopathy: Soluble and Imaging Ocular Biomarkers

Diabetic retinopathy (DR), the most common microvascular complication of diabetes mellitus, represents the leading cause of acquired blindness in the working-age population. Due to the potential absence of symptoms in the early stages of the disease, the identification of clinical biomarkers can hav...

Full description

Bibliographic Details
Main Authors: Mariantonia Ferrara, Alessandra Loda, Giulia Coco, Piergiacomo Grassi, Silvia Cestaro, Sara Rezzola, Vito Romano, Francesco Semeraro
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/12/3/912
_version_ 1797624137908224000
author Mariantonia Ferrara
Alessandra Loda
Giulia Coco
Piergiacomo Grassi
Silvia Cestaro
Sara Rezzola
Vito Romano
Francesco Semeraro
author_facet Mariantonia Ferrara
Alessandra Loda
Giulia Coco
Piergiacomo Grassi
Silvia Cestaro
Sara Rezzola
Vito Romano
Francesco Semeraro
author_sort Mariantonia Ferrara
collection DOAJ
description Diabetic retinopathy (DR), the most common microvascular complication of diabetes mellitus, represents the leading cause of acquired blindness in the working-age population. Due to the potential absence of symptoms in the early stages of the disease, the identification of clinical biomarkers can have a crucial role in the early diagnosis of DR as well as for the detection of prognostic factors. In particular, imaging techniques are fundamental tools for screening, diagnosis, classification, monitoring, treatment planning and prognostic assessment in DR. In this context, the identification of ocular and systemic biomarkers is crucial to facilitate the risk stratification of diabetic patients; moreover, reliable biomarkers could provide prognostic information on disease progression as well as assist in predicting a patient’s response to therapy. In this context, this review aimed to provide an updated and comprehensive overview of the soluble and anatomical biomarkers associated with DR.
first_indexed 2024-03-11T09:38:51Z
format Article
id doaj.art-50a37aeeb4604dccadf091b14b59b32e
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-11T09:38:51Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-50a37aeeb4604dccadf091b14b59b32e2023-11-16T17:09:00ZengMDPI AGJournal of Clinical Medicine2077-03832023-01-0112391210.3390/jcm12030912Diabetic Retinopathy: Soluble and Imaging Ocular BiomarkersMariantonia Ferrara0Alessandra Loda1Giulia Coco2Piergiacomo Grassi3Silvia Cestaro4Sara Rezzola5Vito Romano6Francesco Semeraro7Manchester Royal Eye Hospital, Oxford Road, Manchester M13 9WL, UKDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, ItalyDepartment of Clinical Science and Translational Medicine, University of Rome Tor Vergata, 00133 Rome, ItalyNorthern Care Alliance NHS Foundation Trust, Whitehall St, Rochdale OL12 0NB, UKEye Clinic, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, 25121 Brescia, ItalyDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, ItalyEye Clinic, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, 25121 Brescia, ItalyEye Clinic, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, 25121 Brescia, ItalyDiabetic retinopathy (DR), the most common microvascular complication of diabetes mellitus, represents the leading cause of acquired blindness in the working-age population. Due to the potential absence of symptoms in the early stages of the disease, the identification of clinical biomarkers can have a crucial role in the early diagnosis of DR as well as for the detection of prognostic factors. In particular, imaging techniques are fundamental tools for screening, diagnosis, classification, monitoring, treatment planning and prognostic assessment in DR. In this context, the identification of ocular and systemic biomarkers is crucial to facilitate the risk stratification of diabetic patients; moreover, reliable biomarkers could provide prognostic information on disease progression as well as assist in predicting a patient’s response to therapy. In this context, this review aimed to provide an updated and comprehensive overview of the soluble and anatomical biomarkers associated with DR.https://www.mdpi.com/2077-0383/12/3/912corneal endothelial cell countconfocal microscopydiabetic retinopathyfluorescein angiographyocular biomarkers diabetic retinopathyoptical coherence tomography
spellingShingle Mariantonia Ferrara
Alessandra Loda
Giulia Coco
Piergiacomo Grassi
Silvia Cestaro
Sara Rezzola
Vito Romano
Francesco Semeraro
Diabetic Retinopathy: Soluble and Imaging Ocular Biomarkers
Journal of Clinical Medicine
corneal endothelial cell count
confocal microscopy
diabetic retinopathy
fluorescein angiography
ocular biomarkers diabetic retinopathy
optical coherence tomography
title Diabetic Retinopathy: Soluble and Imaging Ocular Biomarkers
title_full Diabetic Retinopathy: Soluble and Imaging Ocular Biomarkers
title_fullStr Diabetic Retinopathy: Soluble and Imaging Ocular Biomarkers
title_full_unstemmed Diabetic Retinopathy: Soluble and Imaging Ocular Biomarkers
title_short Diabetic Retinopathy: Soluble and Imaging Ocular Biomarkers
title_sort diabetic retinopathy soluble and imaging ocular biomarkers
topic corneal endothelial cell count
confocal microscopy
diabetic retinopathy
fluorescein angiography
ocular biomarkers diabetic retinopathy
optical coherence tomography
url https://www.mdpi.com/2077-0383/12/3/912
work_keys_str_mv AT mariantoniaferrara diabeticretinopathysolubleandimagingocularbiomarkers
AT alessandraloda diabeticretinopathysolubleandimagingocularbiomarkers
AT giuliacoco diabeticretinopathysolubleandimagingocularbiomarkers
AT piergiacomograssi diabeticretinopathysolubleandimagingocularbiomarkers
AT silviacestaro diabeticretinopathysolubleandimagingocularbiomarkers
AT sararezzola diabeticretinopathysolubleandimagingocularbiomarkers
AT vitoromano diabeticretinopathysolubleandimagingocularbiomarkers
AT francescosemeraro diabeticretinopathysolubleandimagingocularbiomarkers